A detailed history of Missouri Trust & Investment CO transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Missouri Trust & Investment CO holds 31 shares of FLGT stock, worth $573. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31
Previous 31 -0.0%
Holding current value
$573
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 02, 2022

BUY
$77.3 - $105.0 $2,396 - $3,255
31 New
31 $3,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $560M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Missouri Trust & Investment CO Portfolio

Follow Missouri Trust & Investment CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Missouri Trust & Investment CO, based on Form 13F filings with the SEC.

News

Stay updated on Missouri Trust & Investment CO with notifications on news.